产品介绍 评论(0)
宿主来源
Mouse分子别名
Low affinity immunoglobulin gamma Fc region receptor II-a, IgG Fc receptor II-a, CDw32, Fc-gamma RII-a (Fc-gamma-RIIa; FcRII-a), FCGR2A, FCG2, FCGR2A1, IGFR2Accession
P12318克隆号
IV.3抗体类型
Mouse mAb抗体同种型
Mouse IgG2b,k反应种属 ?
Hu纯化方式
Protein A浓度
5 mg/ml纯度
>95% (Determined by SDS-PAGE)标记
Unconjugated性状
Liquid缓冲体系
PBS pH7.4, containing no preservative
储存条件
2 to 8 °C for 2 weeks under sterile conditions;
-20 °C for 3 months under sterile conditions;
-80 °C for 24 months under sterile conditions.
Please avoid repeated freeze-thaw cycles.
应用
in vivo FcγRIIA blockade in humanized mice
in vitro FcγRIIA blockade
FCM
ELISA
FcγRIIA is a specific receptor for immunoglobulin G (IgG), belonging to the family of Fcγ receptors (FcγR). Among the FcγRs, FcγRIIA functions as an activating receptor. This receptor is primarily expressed on the membranes of immune cells, such as human platelets, and serves as a bridge between specific antibodies and effector cell functions, tightly linking humoral immunity with cellular immunity. FcγRIIA plays a crucial role in regulating IgG effects, as it can bind to monomeric and immune complex (IC) IgG. It can induce either activation or inhibition of functions, participating in driving antibody effector functions such as antibody-dependent cell-mediated cytotoxicity (ADCC) and/or antibody-dependent cellular phagocytosis (ADCP), as well as antigen presentation and the release of chemokines and cytokines. In autoimmune inflammatory diseases like systemic lupus erythematosus (SLE), the expression of FcγRIIA may exacerbate lupus nephritis and promote platelet activation.







评论(0)